Co-targeting of EGF receptor and neuropilin-1 overcomes cetuximab resistance in pancreatic ductal adenocarcinoma with integrin β1-driven Src-Akt bypass signaling
出版年份 2016 全文链接
标题
Co-targeting of EGF receptor and neuropilin-1 overcomes cetuximab resistance in pancreatic ductal adenocarcinoma with integrin β1-driven Src-Akt bypass signaling
作者
关键词
-
出版物
ONCOGENE
Volume 36, Issue 18, Pages 2543-2552
出版商
Springer Nature
发表日期
2016-10-31
DOI
10.1038/onc.2016.407
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Distinct effects of β1 integrin on cell proliferation and cellular signaling in MDA-MB-231 breast cancer cells
- (2016) Sicong Hou et al. Scientific Reports
- Neuropilin Functions as an Essential Cell Surface Receptor
- (2015) Hou-Fu Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Integrin traffic - the update
- (2015) N. De Franceschi et al. JOURNAL OF CELL SCIENCE
- Immunoglobulin Fc-fused, neuropilin-1-specific peptide shows efficient tumor tissue penetration and inhibits tumor growth via anti-angiogenesis
- (2015) Ye-Jin Kim et al. JOURNAL OF CONTROLLED RELEASE
- Pancreatic cancer: from state-of-the-art treatments to promising novel therapies
- (2015) Ignacio Garrido-Laguna et al. Nature Reviews Clinical Oncology
- Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
- (2015) Laetitia Seguin et al. TRENDS IN CELL BIOLOGY
- Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity
- (2015) Gerald J Prud'homme et al. Oncotarget
- In Pancreatic Carcinoma, Dual EGFR/HER2 Targeting with Cetuximab/Trastuzumab Is More Effective than Treatment with Trastuzumab/Erlotinib or Lapatinib Alone: Implication of Receptors' Down-regulation and Dimers' Disruption
- (2015) Christel Larbouret et al. NEOPLASIA
- Cotargeting of Epidermal Growth Factor Receptor and PI3K Overcomes PI3K-Akt Oncogenic Dependence in Pancreatic Ductal Adenocarcinoma
- (2014) M. H. Wong et al. CLINICAL CANCER RESEARCH
- Protein kinase LKB1 promotes RAB7-mediated neuropilin-1 degradation to inhibit angiogenesis
- (2014) Imoh S. Okon et al. JOURNAL OF CLINICAL INVESTIGATION
- A general strategy for generating intact, full-length IgG antibodies that penetrate into the cytosol of living cells
- (2014) Dong-Ki Choi et al. mAbs
- Tumor-Penetrating iRGD Peptide Inhibits Metastasis
- (2014) K. N. Sugahara et al. MOLECULAR CANCER THERAPEUTICS
- Enhancement of the Tumor Penetration of Monoclonal Antibody by Fusion of a Neuropilin-Targeting Peptide Improves the Antitumor Efficacy
- (2014) T.-H. Shin et al. MOLECULAR CANCER THERAPEUTICS
- Drugging the undruggable RAS: Mission Possible?
- (2014) Adrienne D. Cox et al. NATURE REVIEWS DRUG DISCOVERY
- Bispecific Antibody to ErbB2 Overcomes Trastuzumab Resistance through Comprehensive Blockade of ErbB2 Heterodimerization
- (2013) B. Li et al. CANCER RESEARCH
- Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin 1/Src/Akt-Driven Bypass Signaling
- (2013) R. Kanda et al. CANCER RESEARCH
- A Heterodimeric Fc-Based Bispecific Antibody Simultaneously Targeting VEGFR-2 and Met Exhibits Potent Antitumor Activity
- (2013) H.-J. Choi et al. MOLECULAR CANCER THERAPEUTICS
- The quest to overcome resistance to EGFR-targeted therapies in cancer
- (2013) Curtis R Chong et al. NATURE MEDICINE
- Neuropilin-1Stimulates Tumor Growth by Increasing Fibronectin Fibril Assembly in the Tumor Microenvironment
- (2012) Usman Yaqoob et al. CANCER RESEARCH
- Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor
- (2012) M Iida et al. ONCOGENE
- Distinct Recycling of Active and Inactive β1 Integrins
- (2012) Antti Arjonen et al. TRAFFIC
- Reconstruction of integrin activation
- (2011) F. Ye et al. BLOOD
- Epidermal Growth Factor Receptor in Pancreatic Cancer
- (2011) Melissa Oliveira-Cunha et al. Cancers
- Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity
- (2010) H Jia et al. BRITISH JOURNAL OF CANCER
- Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205
- (2010) Philip A. Philip et al. JOURNAL OF CLINICAL ONCOLOGY
- Understanding resistance to EGFR inhibitors—impact on future treatment strategies
- (2010) Deric L. Wheeler et al. Nature Reviews Clinical Oncology
- A novel agonistic antibody to human death receptor 4 induces apoptotic cell death in various tumor cells without cytotoxicity in hepatocytes
- (2009) E.-S. Sung et al. MOLECULAR CANCER THERAPEUTICS
- Neuropilin-1/GIPC1 Signaling Regulates α5β1 Integrin Traffic and Function in Endothelial Cells
- (2009) Donatella Valdembri et al. PLOS BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now